Why Farbe Firma is the Top Manufacturer of Morphine Sulphate Injection
- Maulik Sudani
- Jun 8
- 7 min read
Last Updated: June 8, 2026
TL;DR: Morphine Sulphate Injection — a sterile aqueous solution of morphine sulphate, the prototypical strong opioid analgesic, supplied commonly as 10 mg/mL or 15 mg/mL solutions in 1 mL ampoules for intravenous, intramuscular or subcutaneous administration — is a cornerstone agent for the management of severe acute and chronic pain, including post-operative, cancer, myocardial-infarction and palliative-care pain, where milder analgesics are inadequate. Morphine is a potent mu-opioid receptor agonist, so each ampoule must deliver an exact, sterile, particulate-free dose, and because it is an internationally controlled narcotic its manufacture demands not only pharmaceutical quality but also rigorous controlled-substance custody, reconciliation and security. Its safety depends on a precise stability-indicating assay, a tightly controlled impurity and oxidative-degradation profile, oxygen protection, low particulate and endotoxin, correctly held pH and robust ampoule container-closure integrity, all under a fully auditable narcotic-control chain. Farbe Firma Pvt Ltd manufactures WHO-GMP certified Morphine Sulphate Injection at our Gujarat, India facility under appropriate narcotic licensing and supplies it to hospital pharmacy, anaesthesia, oncology, emergency and palliative-care services, government tenders, licensed distributors and brand owners across 30+ countries.
Key Takeaways
Drug class: Strong opioid (mu-receptor agonist) analgesic — Morphine Sulphate Injection manages severe acute and chronic pain, including post-operative, cancer, myocardial-infarction and palliative-care pain, where weaker analgesics are insufficient, delivering potent, titratable opioid analgesia by the intravenous, intramuscular or subcutaneous route.
Certified manufacturing: WHO-GMP certified plant, ISO Class 5 aseptic core, validated water-for-injection loops, qualified nitrogen-purged ampoule filling lines, dedicated control of the stability-indicating assay, the impurity profile, pH, particulate and endotoxin, with container-closure integrity verification on every batch — all operated under controlled-substance custody and reconciliation.
CTD-ACTD dossier support: Full eCTD and ACTD modules, ICH Q1A long-term and accelerated stability data, ICH Q1B photostability data, drug master files and CEP-style documentation for registrations including ministry-of-health, hospital-formulary, narcotic-board and institutional tenders.
End-to-end CDMO services: Licensed controlled-substance contract manufacturing, third-party manufacturing, private-label artwork, multilingual leaflets, tamper-evident tender-ready ampoule packaging and import/export permit coordination for buyers in Africa, LATAM, CIS, GCC, MENA and Southeast Asia.
Introduction: Why Morphine Sulphate Injection Demands a Premium Manufacturer
Morphine Sulphate Injection occupies a cornerstone place in anaesthesia, oncology, emergency medicine and palliative care across every market. It is the strong opioid that clinicians reach for when pain is severe and milder analgesics fall short — in post-operative pain, in cancer pain, in the acute pain of myocardial infarction and in end-of-life palliative care, where reliable, titratable analgesia is essential to humane treatment. Given intravenously, intramuscularly or subcutaneously, it provides rapid, potent and dose-adjustable pain relief. In each of these settings the dose delivered from each small ampoule must be exact, sterile and reliably the same from unit to unit, because with a potent opioid even small variations in delivered dose matter.
That clinical reality places real demands on the manufacturer — and morphine adds a second layer those demands rarely face elsewhere. As an internationally scheduled narcotic, its manufacture requires licensed handling, secured storage, gram-level reconciliation of active and finished units, and a fully auditable custody chain alongside the usual pharmaceutical controls. Chemically, morphine sulphate in solution is prone to oxidative degradation and is pH-sensitive, so the injectable must stay clear, correctly potent and free of degradation products across shelf life. The assay must be exact; the impurity and oxidative-degradation profile must stay within tight limits; the solution must be particulate-free, low in endotoxin, held at the right slightly acidic pH and protected from oxygen, then sealed in an ampoule whose integrity is verified. Choosing a Morphine Sulphate Injection manufacturer that treats the stability-indicating assay, oxidation control, impurity profiling, particulate and endotoxin control, container-closure integrity and narcotic-custody compliance as core disciplines is what protects the patient — and the supply chain — at the point of care.
What Sets a World-Class Morphine Sulphate Injection Manufacturer Apart
A world-class manufacturer of Morphine Sulphate Injection invests in three areas that weaker suppliers underfund: a precise, stability-indicating assay of morphine together with tight control of its oxidative related-substance and degradation-product profile by HPLC, robust aseptic filling of an oxidation-prone aqueous solution into ampoules under inert-gas (nitrogen) protection with verified container-closure integrity, and a licensed, fully auditable controlled-substance custody system layered over tender-ready dossier support for a product procured through hospital-formulary, narcotic-board and ministry-of-health channels. It starts with the active — pharmacopoeial-grade morphine sulphate sourced from licensed, qualified, audited narcotic API makers, received under secured, reconciled custody, with full assay, related-substance and impurity profiling and certificates of analysis verified by the receiving laboratory before the material enters production.
Formulation, filling and sealing then have to protect both the assay and the dose. The bulk solution is compounded in water-for-injection that is purged with nitrogen to displace dissolved oxygen, at controlled slightly acidic pH, sterile-filtered through 0.22 µm membrane and filled aseptically into ampoules with nitrogen headspace overlay under ISO Class 5 air. The oxygen-control, filling and sealing parameters are locked in the master batch record, because for a potent opioid the assay and the degradation-product profile govern both the efficacy and the safety of every ampoule. Each ampoule is fusion-sealed and 100 % inspected for particulate matter, fill volume, seal quality and cosmetic defects; in-process and release testing confirm morphine assay by validated HPLC, the related-substance profile, pH, clarity of the solution, and endotoxin is held well within limits so the injection is safe for intravenous, intramuscular or subcutaneous administration — while every gram of active and every finished ampoule is reconciled through the controlled-substance ledger.
Quality Systems Behind Every Morphine Sulphate Injection
Every Farbe Firma Morphine Sulphate Injection batch is released only after a full stack of quality checks: stability-indicating HPLC assay of morphine against pharmacopoeial reference standards, control of related substances and oxidative degradation products by HPLC, pH and osmolarity, clarity and colour of the solution, visible and sub-visible particulate matter, bacterial endotoxin by LAL, sterility by membrane filtration, fill-volume verification and container-closure integrity for the ampoule format. Certificates of analysis are issued with full traceability back to the narcotic API lot, the primary-packaging lot and the qualified person responsible for release — and reconciled against the controlled-substance custody record.
Around those release tests sits a deeper quality and security architecture: validated water-for-injection generation and looped distribution, qualified HVAC with continuous environmental monitoring, validated nitrogen-purge and inert-overlay systems, calibrated sterilisation and depyrogenation equipment, validated ampoule filling lines with 100 % inspection, secured controlled-substance vaults with access control and gram-level reconciliation, and an electronic batch record system tied into our deviation, change-control and CAPA workflows. Because morphine is oxidation-prone and its assay drives both efficacy and shelf life, we treat the stability-indicating HPLC assay and the oxidative-degradation result as critical quality attributes and trend them across batches, not merely as one-off release tests. Stability is tracked under both long-term (30 °C / 65 % RH) and accelerated (40 °C / 75 % RH) ICH Q1A conditions, with ICH Q1B photostability challenge, and the product is protected from oxygen and light through nitrogen overlay and appropriate primary and secondary packaging.
Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry
Why Farbe Firma is the Trusted Morphine Sulphate Injection manufacturer for Global Buyers
Farbe Firma Pvt Ltd manufactures more than 100 sterile injectables across analgesic, anaesthetic, critical-care, anti-infective and supportive-care categories. For Morphine Sulphate Injection specifically, we supply 10 mg/mL and 15 mg/mL solutions in 1 mL ampoules under WHO-GMP conditions and appropriate narcotic licensing, with country-specific strengths, fill volumes, tamper-evident packs and pack configurations available under controlled-substance contract manufacturing agreements. Every batch is released to WHO-GMP standards, with the underlying CTD or ACTD dossier — including the stability-indicating-assay and oxidative-impurity data package — ready to hand for registration, narcotic-board approval and tender qualification.
Our CDMO services scale cleanly from single-hospital supply to full national tender procurement, with the added controlled-substance layer handled in-house. We prepare complete eCTD and ACTD modules, drug master files, ICH Q1A stability and ICH Q1B photostability packages, assay and related-substances method-validation data, translated package inserts and artwork for Spanish, French, Portuguese, Russian and Arabic markets, and coordinate the import/export permits, narcotic-control documentation, shipping and logistics that a scheduled opioid requires. When a buyer needs Morphine Sulphate Injection at tender scale our regulatory, manufacturing, narcotic-compliance and logistics teams move as one: dossier, validation reports, permits, artwork, filling-line slot and secured shipment plan delivered as a single coordinated package.
Buyers stay with Farbe Firma because of audit-readiness, narcotic-compliance discipline and communication. Customer and regulatory auditors are welcomed onto the plant floor, into the filling suite and into the controlled-substance vault records; our quality unit answers technical queries with primary data, not slogans; and our reviewer team — practising pharmacists and R&D scientists — can talk through licensed API sourcing, stability-indicating assay development, oxidative-degradation and related-substance control, nitrogen-purge strategy, pH and tonicity, particulate and endotoxin control, container-closure integrity, narcotic reconciliation and shelf-life choices in real detail. For a potent, internationally controlled opioid where assay accuracy, oxidation control and an unbroken custody chain directly govern both patient safety and supply-chain integrity, that openness is exactly what global buyers tell us they value most.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma a WHO-GMP certified Morphine Sulphate Injection manufacturer?
Yes. Farbe Firma Pvt Ltd holds WHO-GMP certification and manufactures Morphine Sulphate Injection under appropriate narcotic licensing at a Gujarat, India facility with ISO Class 5 aseptic processing, nitrogen-purged filling, qualified ampoule filling lines, qualified water-for-injection systems, secured controlled-substance custody, 100 % ampoule inspection and continuous environmental monitoring.
Which strengths and pack sizes of Morphine Sulphate Injection do you supply?
Our standard presentations are 10 mg/mL and 15 mg/mL sterile aqueous solutions in 1 mL ampoules. Custom strengths, fill volumes, tamper-evident ampoule counts per pack and country-specific artwork are available under controlled-substance contract manufacturing agreements.
How does Farbe Firma handle the controlled-substance requirements for Morphine Sulphate Injection?
As an internationally scheduled narcotic, morphine is manufactured under appropriate licensing with secured, access-controlled vaults, gram-level reconciliation of active and finished units, a fully auditable custody chain, and coordination of import/export permits and narcotic-board documentation alongside the standard WHO-GMP pharmaceutical controls.
Can Farbe Firma support country-specific registrations for Morphine Sulphate Injection?
Yes. We provide full CTD and ACTD dossier modules, drug master files, ICH Q1A stability and ICH Q1B photostability packages, assay and related-substances method-validation data, and translated package inserts and artwork for Spanish, French, Portuguese, Russian and Arabic markets. We support registrations, narcotic-board approval and tender qualification in 30+ countries across Africa, LATAM, CIS, GCC, MENA and Southeast Asia, subject to applicable narcotic import/export controls.
What is the minimum order quantity for Morphine Sulphate Injection contract manufacturing?
MOQs vary by strength, ampoule size, fill volume, label complexity, dossier requirements and applicable narcotic-licensing conditions. For our ampoule presentations we accommodate hospital-scale and full national-tender-scale orders. Contact director@farbefirma.org for a specific quotation.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments